U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
Pegunigalsidase Alfa
8M7V7Q6537
US Approved Rx (2023)
First approved in 2023
General
Names
6
Classification
2
Identifiers
7
Subunits
2
Related Substances
1
Pegunigalsidase Alfa
8M7V7Q6537
US Approved Rx (2023)
First approved in 2023
General
Approval Year
2023
455
Names
6
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
Pegunigalsidase Alfa
Official Name
English
PRX-102
Code
English
PEGUNIGALSIDASE ALFA [USAN]
Common Name
English
Pegunigalsidase alfa [WHO-DD]
Common Name
English
pegunigalsidase alfa [INN]
Common Name
English
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Classification
2
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Positive
EU ORPHAN DRUG
Positive
Treatment of Fabry disease
EU-Orphan Drug
EU/3/17/1953
Designated
ORPHAN DRUG
Designated
Treatment of Fabry's disease
FDA ORPHAN DRUG
162302
Showing 1 to 2 of 2 entries
Previous
1
Next
Identifiers
7
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
CAS
1644392-61-9
PRIMARY
DRUG BANK
DB14992
PRIMARY
USAN
GH-87
PRIMARY
PUBCHEM
121488171
PRIMARY
FDA UNII
8M7V7Q6537
PRIMARY
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Subunits
2
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Related Substances
1
ACTIVE MOIETY
8M7V7Q6537
Pegunigalsidase Alfa
